Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Cardiac Rehabilitation Program in Peripheral Arterial Disease

Condition:   Peripheral Arterial Disease
Interventions:   Other: Cardiac Rehabilitation Program;   Other: Conventional Therapy
Sponsor:   University of Kansas Medical Center
Recruiting - verified August 2017

Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers

Conditions:   Ulcer;   Diabetes Mellitus
Interventions:   Device: Light emitting diodes (LED);   Device: Fixed diphasic current
Sponsor:   University of Sao Paulo
Not yet recruiting - verified August 2017

N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes

Conditions:   Diabetes Mellitus;   Critical Limb Ischemia;   Lower Limb Amputation Knee;   Peripheral Arterial Disease
Interventions:   Drug: Active Arm N-acetyl cysteine (NAC);   Drug: Placebo Arm
Sponsor:   Washington University School of Medicine
Recruiting - verified August 2017

Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)

Conditions:   Peripheral Artery Disease;   Vascular Disease;   Critical Limb Ischemia
Intervention:   Device: Injection of cBMA aspirate into the index leg
Sponsors:   Michael Murphy;   Zimmer Biomet
Active, not recruiting - verified August 2017

A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation

Conditions:   Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease;   Vascular Disease;   Arterial Occlusive Disease;   Arteriosclerosis;   Atherosclerosis;   Cardiovascular Disease;   Pathologic Processes;   Orthopedic Procedures;   Amputation
Intervention:   Biological: Allogeneic bone marrow derived mesenchymal stem cells
Sponsor:   Indiana University
Recruiting - verified August 2017

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Recruiting - verified August 2017